BRPI0921654A2 - formulação farmacêutica - Google Patents

formulação farmacêutica

Info

Publication number
BRPI0921654A2
BRPI0921654A2 BRPI0921654A BRPI0921654A BRPI0921654A2 BR PI0921654 A2 BRPI0921654 A2 BR PI0921654A2 BR PI0921654 A BRPI0921654 A BR PI0921654A BR PI0921654 A BRPI0921654 A BR PI0921654A BR PI0921654 A2 BRPI0921654 A2 BR PI0921654A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
BRPI0921654A
Other languages
English (en)
Inventor
Michele Virno
Original Assignee
Advance Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40512558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0921654(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advance Holdings Ltd filed Critical Advance Holdings Ltd
Publication of BRPI0921654A2 publication Critical patent/BRPI0921654A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BRPI0921654A 2008-11-28 2009-11-11 formulação farmacêutica BRPI0921654A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08170177 2008-11-28
PCT/EP2009/064971 WO2010060798A1 (en) 2008-11-28 2009-11-11 Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester

Publications (1)

Publication Number Publication Date
BRPI0921654A2 true BRPI0921654A2 (pt) 2016-02-10

Family

ID=40512558

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921654A BRPI0921654A2 (pt) 2008-11-28 2009-11-11 formulação farmacêutica

Country Status (15)

Country Link
US (1) US20110275717A1 (pt)
EP (1) EP2364140A1 (pt)
JP (1) JP2012510439A (pt)
KR (1) KR20110091862A (pt)
CN (1) CN102227211A (pt)
AU (1) AU2009319167A1 (pt)
BR (1) BRPI0921654A2 (pt)
CA (1) CA2742645A1 (pt)
CL (1) CL2011001225A1 (pt)
EA (1) EA201100863A1 (pt)
IL (1) IL212602A0 (pt)
MX (1) MX2011005410A (pt)
NZ (1) NZ592647A (pt)
WO (1) WO2010060798A1 (pt)
ZA (1) ZA201103335B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2463038C2 (ru) 2006-10-17 2012-10-10 Нуво Рисерч Инк. Диклофенаковый гель
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
CN104428003B (zh) 2012-07-12 2020-03-10 辉凌公司 双氯芬酸制剂
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
CN104274436B (zh) * 2013-07-03 2017-05-10 成都力思特制药股份有限公司 双氯芬酸钠盐酸利多卡因复方药物注射液及其制备方法
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
KR101654900B1 (ko) * 2016-02-04 2016-09-07 주식회사 한국루베 저독성 화생방 제독제
WO2021048748A1 (en) 2019-09-09 2021-03-18 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
EP4150103B1 (de) * 2020-05-12 2025-04-09 U. Windmöller Innovation GmbH & Co. KG Verfahren zur herstellung von hydroxyfettsäurebasierten polyolen
CN112516081B (zh) * 2020-12-16 2023-03-10 郑州百瑞动物药业有限公司 一种双氯芬酸注射液及其制备方法
EP4112042B1 (en) * 2021-06-30 2026-02-18 Haleon CH SARL Nanoemulsion comprising diclofenac
EP4499036A1 (en) 2022-03-25 2025-02-05 Glycores 2000 srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof
CN116687883A (zh) * 2023-06-25 2023-09-05 湖南一格制药有限公司 一种凝胶贴膏的制备方法及凝胶贴膏
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (pt) * 1982-10-07 1986-05-15
ATE103182T1 (de) * 1989-09-21 1994-04-15 Ciba Vision Ag Antimikrobielle zusammensetzungen.
JP4275751B2 (ja) * 1996-12-27 2009-06-10 久光製薬株式会社 外用組成物
NZ502567A (en) * 1997-07-29 2002-03-28 Upjohn Co Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
CA2583315A1 (en) * 2004-10-06 2006-06-01 Tiltan Pharma Ltd. Method and composition for enhancing anti-angiogenic therapy
US7838513B2 (en) * 2006-07-07 2010-11-23 Tiltan Pharma Ltd. Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent
DE102007014947B4 (de) * 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilisierte wässrige Lösungen von Ergolinverbindungen

Also Published As

Publication number Publication date
EP2364140A1 (en) 2011-09-14
WO2010060798A1 (en) 2010-06-03
US20110275717A1 (en) 2011-11-10
JP2012510439A (ja) 2012-05-10
KR20110091862A (ko) 2011-08-16
IL212602A0 (en) 2011-07-31
EA201100863A1 (ru) 2011-12-30
AU2009319167A1 (en) 2010-06-03
CN102227211A (zh) 2011-10-26
CL2011001225A1 (es) 2011-11-11
NZ592647A (en) 2013-05-31
ZA201103335B (en) 2012-01-25
MX2011005410A (es) 2011-06-16
CA2742645A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
CY2018030I1 (el) Φαρμακοτεχνικη μορφη 514
LTC2140867I2 (lt) Farmacinė kompozicija
SMT201400069B (it) Formulazione farmaceutica
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0921654A2 (pt) formulação farmacêutica
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI1004940A2 (pt) composição farmacêutica
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0721651A2 (pt) Composição farmacêutica
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2451274A4 (en) Pharmaceutical compositions
BRPI0912026A2 (pt) formulação homeopática
BRPI1009465A2 (pt) Formulação
BRPI1015939A2 (pt) composição farmacêutica
DK2285413T3 (da) Farmaceutisk sammensætning
DK2120884T3 (da) Farmaceutisk sammensætning
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
PL2379086T3 (pl) Preparat farmeceutyczny
EP2236149A4 (en) MEDICAL COMPOSITION
BRPI0921313A2 (pt) composição farmaucêutica
PT2209464E (pt) Composição farmacêutica antimalárica
EP2296713A4 (en) DISINFECTANT FORMULATION

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B25A Requested transfer of rights approved

Owner name: LECTIO PHARMAENTWICKLUNGS-UND VERWERTUNGS GMBH (AT

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]